Pulmonary blastomycosis

Seminars in Respiratory and Critical Care Medicine

Volumn 32, Issue 6, 2011, Pages 745-753

  Bariola, J Ryan ^a,b   Vyas, Keyur S ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Blastomyces dermatitidis; Blastomycosis; fungal pneumonia; pneumonia; pulmonary infection

Indexed keywords

AMPHOTERICIN B; FUNGUS ANTIGEN; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLASTOMYCES DERMATITIDIS; BLASTOMYCOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FUNGUS CULTURE; HUMAN; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; URINALYSIS;

ANTIFUNGAL AGENTS; BLASTOMYCES; BLASTOMYCOSIS; HUMANS; LUNG DISEASES, FUNGAL; NORTH AMERICA;

EID: 83655202770     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0031-1295722     Document Type: Article

References (102)

1. Gilchrist T C., Stokes W R. A case of pseudo-lupus vulgaris caused by a Blastomyces. J Exp Med 1898 3 1 53-78
2. Witorsch P, Utz J P. North American blastomycosis: a study of 40 patients. Medicine (Baltimore) 1968 47 3 169-200
3. Sarosi G A., Davies S F. Blastomycosis. Am Rev Respir Dis 1979 120 4 911-938 (Pubitemid 10194959)
4. Nemecek J C., Wüthrich M, Klein B S. Global control of dimorphism and virulence in fungi. Science 2006 312 5773 583-588
5. Drutz D J., Frey C L. Intracellular and extracellular defenses of human phagocytes against Blastomyces dermatitidis conidia and yeasts. J Lab Clin Med 1985 105 6 737-750 (Pubitemid 16053028)
6. Sugar A M., Picard M. Macrophage- and oxidant-mediated inhibition of the ability of live Blastomyces dermatitidis conidia to transform to the pathogenic yeast phase: implications for the pathogenesis of dimorphic fungal infections. J Infect Dis 1991 163 2 371-375
7. Rocco N M., Carmen J C., Klein B S. Blastomyces dermatitidis yeast cells inhibit nitric oxide production by alveolar macrophage inducible nitric oxide synthase. Infect Immun 2011 79 6 2385-2395
8. Hogan L H., Klein B S. Altered expression of surface alpha-1,3-glucan in genetically related strains of Blastomyces dermatitidis that differ in virulence. Infect Immun 1994 62 8 3543-3546 (Pubitemid 24232144)
9. Newman S L., Chaturvedi S, Klein B S. The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. J Immunol 1995 154 2 753-761
10. Brandhorst T T., Wüthrich M, Warner T, Klein B. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis. J Exp Med 1999 189 8 1207-1216 (Pubitemid 29198259)
11. Finkel-Jimenez B, Wüthrich M, Brandhorst T, Klein B S. The WI-1 adhesin blocks phagocyte TNF-alpha production, imparting pathogenicity on Blastomyces dermatitidis. J Immunol 2001 166 4 2665-2673 (Pubitemid 32173506)
12. Finkel-Jimenez B, Wüthrich M, Klein B S. BAD1, an essential virulence factor of Blastomyces dermatitidis, suppresses host TNF-alpha production through TGF-beta-dependent and -independent mechanisms. J Immunol 2002 168 11 5746-5755 (Pubitemid 34556159)
13. Zhang M X., Brandhorst T T., Kozel T R., Klein B S. Role of glucan and surface protein BAD1 in complement activation by Blastomyces dermatitidis yeast. Infect Immun 2001 69 12 7559-7564 (Pubitemid 33086582)
14. Bradsher R W., Chapman S W., Pappas P G. Blastomycosis. Infect Dis Clin North Am 2003 17 1 21-40 vii (Pubitemid 36514569)
15. Baumgardner D J., Steber D, Glazier R et al. Geographic information system analysis of blastomycosis in northern Wisconsin, USA: waterways and soil. Med Mycol 2005 43 2 117-125 (Pubitemid 40439399)
16. Dworkin M S., Duckro A N., Proia L, Semel J D., Huhn G. The epidemiology of blastomycosis in Illinois and factors associated with death. Clin Infect Dis 2005 41 12 e107-e111
17. Morris S K., Brophy J, Richardson S E. et al. Blastomycosis in Ontario, 1994-2003. Emerg Infect Dis 2006 12 2 274-279
18. Centers for Disease Control and Prevention. BlastomycosisWisconsin, 19861995. MMWR Morb Mortal Wkly Rep 1996 45 601-603
19. Chu J H., Feudtner C, Heydon K, Walsh T J., Zaoutis T E. Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis 2006 42 6 822-825 (Pubitemid 43363939)
20. Klein B S., Vergeront J M., Weeks R J. et al. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med 1986 314 9 529-534 (Pubitemid 16128059)
21. Klein B S., Vergeront J M., DiSalvo A F., Kaufman L, Davis J P. Two outbreaks of blastomycosis along rivers in Wisconsin. Isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways. Am Rev Respir Dis 1987 136 6 1333-1338 (Pubitemid 18030260)
22. Proctor M E., Klein B S., Jones J M., Davis J P. Cluster of pulmonary blastomycosis in a rural community: evidence for multiple high-risk environmental foci following a sustained period of diminished precipitation. Mycopathologia 2002 153 3 113-120 (Pubitemid 34294421)
23. Pfister J R., Archer J R., Hersil S et al. Non-rural point source blastomycosis outbreak near a yard waste collection site. Clin Med Res 2011 9 2 57-65
24. Carlos W G., Rose A S., Wheat L J. et al. Blastomycosis in Indiana: digging up more cases. Chest 2010 138 6 1377-1382
25. Denton J F., Disalvo A F. Isolation of Blastomyces dermatitidis from natural sites in Augusta, Georgia. Am J Trop Med Hyg 1964 13 716-722
26. Bakerspigel A, Kane J, Schaus D. Isolation of Blastomyces dermatitidis from an earthen floor in southwestern Ontario, Canada. J Clin Microbiol 1986 24 5 890-891 (Pubitemid 17169437)
27. Burgess J W., Schwan W R., Volk T J. PCR-based detection of DNA from the human pathogen Blastomyces dermatitidis from natural soil samples. Med Mycol 2006 44 8 741-748 (Pubitemid 44824452)
28. Dwight P J., Naus M, Sarsfield P, Limerick B. An outbreak of human blastomycosis: the epidemiology of blastomycosis in the Kenora catchment region of Ontario, Canada. Can Commun Dis Rep 2000 26 10 82-91
29. Vaaler A K., Bradsher R W., Davies S F. Evidence of subclinical blastomycosis in forestry workers in northern Minnesota and northern Wisconsin. Am J Med 1990 89 4 470-476 (Pubitemid 20365397)
30. Landis F B., Varkey B. Late relapse of pulmonary blastomycosis after adequate treatment with amphotericin B. Case report. Am Rev Respir Dis 1976 113 1 77-81
31. Lemos L B., Baliga M, Guo M. Blastomycosis: the great pretender can also be an opportunist: initial clinical diagnosis and underlying diseases in 123 patients. Ann Diagn Pathol 2002 6 3 194-203 (Pubitemid 34700859)
32. Pappas P G., Pottage J C., Powderly W G. et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1992 116 10 847-853 (Pubitemid 23034764)
33. Pappas P G. Blastomycosis in the immunocompromised patient. Semin Respir Infect 1997 12 3 243-251 (Pubitemid 27411208)
34. Gauthier G M., Safdar N, Klein B S., Andes D R. Blastomycosis in solid organ transplant recipients. Transpl Infect Dis 2007 9 4 310-317 (Pubitemid 350059144)
35. Harris J R., Blaney D D., Lindsley M D. et al. Blastomycosis in man after kinkajou bite. Emerg Infect Dis 2011 17 2 268-270
36. Farber E R., Leahy M S., Meadows T R. Endometrial blastomycosis acquired by sexual contact. Obstet Gynecol 1968 32 2 195-199
37. Maxson S, Miller S F., Tryka F, Schutze G E. Perinatal blastomycosis: a review. Pediatr Infect Dis J 1992 11 760-763
38. Bradsher R W., Rice D C., Abernathy R S. Ketoconazole therapy for endemic blastomycosis. Ann Intern Med 1985 103 6 Pt 1 872-879 (Pubitemid 16175497)
39. Halvorsen R A., Duncan J D., Merten D F., Gallis H A., Putman C E. Pulmonary blastomycosis: radiologic manifestations. Radiology 1984 150 1 1-5 (Pubitemid 14212267)
40. Sheflin J R., Campbell J A., Thompson G P. Pulmonary blastomycosis: findings on chest radiographs in 63 patients. AJR Am J Roentgenol 1990 154 6 1177-1180 (Pubitemid 20179457)
41. Brown L R., Swensen S J., Van Scoy R E., Prakash U B., Coles D T., Colby T V. Roentgenologic features of pulmonary blastomycosis. Mayo Clin Proc 1991 66 1 29-38
42. Rabinowitz J G., Busch J B., Buttram W R. Pulmonary manifestations of blastomycosis: radiological support of a new concept. Radiology 1976 120 1 25-32
43. Bariola J R., Hage C A., Durkin M et al. Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis. Diagn Microbiol Infect Dis 2011 69 2 187-191
44. Hawley C, Felson B. Roentgen aspects of intrathoracic blastomycosis. Am J Roentgenol Radium Ther Nucl Med 1956 75 4 751-757
45. OMarro S D., Varkey B. Unexpected recovery of Blastomyces dermatitidis from an anaerobic pleural empyema. Am J Med 1989 86 6 Pt 2 833
46. Arora N S., Oblinger M J., Feldman P S. Chronic pleural blastomycosis with hyperprolactinemia, galactorrhea, and amenorrhea. Am Rev Respir Dis 1979 120 2 451-455 (Pubitemid 9245961)
47. Griffith J E., Campbell G D. Acute miliary blastomycosis presenting as fluminating respiratory failure. Chest 1979 75 5 630-632 (Pubitemid 9178598)
48. Berger R, Kraman S. Acute miliary blastomycosis after short-course corticosteroid treatment. Arch Intern Med 1981 141 9 1223-1225 (Pubitemid 11017510)
49. Stelling C B., Woodring J H., Rehm S R., Hopper D W., Noble R C. Miliary pulmonary blastomycosis. Radiology 1984 150 1 7-13 (Pubitemid 14212268)
50. Evans M E., Haynes J B., Atkinson J B., Delvaux T C. Jr, Kaiser A B. Blastomyces dermatitidis and the adult respiratory distress syndrome: case reports and review of the literature. Am Rev Respir Dis 1982 126 6 1099-1102 (Pubitemid 13202271)
51. Thiele J S., Buechner H A., Deshotels S J. Jr. Blastomycosis and the adult respiratory distress syndrome. J La State Med Soc 1984 136 11 38-40
52. Skillrud D M., Douglas W W. Survival in adult respiratory distress syndrome caused by blastomycosis infection. Mayo Clin Proc 1985 60 4 266-269 (Pubitemid 15091415)
53. Meyer K C., McManus E J., Maki D G. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. N Engl J Med 1993 329 17 1231-1236 (Pubitemid 23306324)
54. Mukkamala R, Mehta J B., Myers J W., Cole C P. Pulmonary blastomycosis with acute respiratory failure as predominant clinical feature. South Med J 1997 90 8 847-850 (Pubitemid 27330315)
55. Lemos L B., Baliga M, Guo M. Acute respiratory distress syndrome and blastomycosis: presentation of nine cases and review of the literature. Ann Diagn Pathol 2001 5 1 1-9 (Pubitemid 32178951)
56. Lemos L B., Guo M, Baliga M. Blastomycosis: organ involvement and etiologic diagnosis. A review of 123 patients from Mississippi. Ann Diagn Pathol 2000 4 6 391-406 (Pubitemid 32006486)
57. Martynowicz M A., Prakash U B. Pulmonary blastomycosis: an appraisal of diagnostic techniques. Chest 2002 121 3 768-773 (Pubitemid 34251440)
58. Hage C A., Davis T E., Fuller D et al. Diagnosis of histoplasmosis by antigen detection in BAL fluid. Chest 2010 137 3 623-628
59. Patel A J., Gattuso P, Reddy V B. Diagnosis of blastomycosis in surgical pathology and cytopathology: correlation with microbiologic culture. Am J Surg Pathol 2010 34 2 256-261
60. Durkin M, Witt J, Lemonte A, Wheat B, Connolly P. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 2004 42 10 4873-4875 (Pubitemid 39362430)
61. Turner S, Kaufman L. Immunodiagnosis of blastomycosis. Semin Respir Infect 1986 1 1 22-28
62. Bradsher R W., Pappas P G. Detection of specific antibodies in human blastomycosis by enzyme immunoassay. South Med J 1995 88 12 1256-1259
63. Klein B S., Vergeront J M., Kaufman L et al. Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin. J Infect Dis 1987 155 2 262-268 (Pubitemid 17022867)
64. Klein B S., Jones J M. Isolation, purification, and radiolabeling of a novel 120-kD surface protein on Blastomyces dermatitidis yeasts to detect antibody in infected patients. J Clin Invest 1990 85 1 152-161 (Pubitemid 20030304)
65. Soufleris A J., Klein B S., Courtney B T., Proctor M E., Jones J M. Utility of anti-WI-1 serological testing in the diagnosis of blastomycosis in Wisconsin residents. Clin Infect Dis 1994 19 1 87-92 (Pubitemid 24227040)
66. Sarosi G A., Davies S F., Phillips J R. Self-limited blastomycosis: a report of 39 cases. Semin Respir Infect 1986 1 1 40-44
67. Recht L D., Philips J R., Eckman M R., Sarosi G A. Self-limited blastomycosis: a report of thirteen cases. Am Rev Respir Dis 1979 120 5 1109-1112 (Pubitemid 10218500)
68. Saccente M, Woods G L. Clinical and laboratory update on blastomycosis. Clin Microbiol Rev 2010 23 2 367-381
69. Chapman S W., Dismukes W E., Proia L A. et al, Infectious Diseases Society of America. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2008 46 12 1801-1812
70. Harrell E R., Curtis A C. The treatment of North American blastomycosis with amphotericin B. AMA Arch Derm 1957 76 5 561-568 discussion 568-569
71. Busey J F. Blastomycosis: a review of 198 collected cases in VA hospitals. Am Rev Respir Dis 1964 89 659-672
72. Lockwood W R., Allison F Jr, Batson B E., Busey J F. The treatment of North American blastomycosis. Ten years experience. Am Rev Respir Dis 1969 100 3 314-320
73. Parker J D., Doto I L., Tosh F E. A decade of experience with blastomycosis and its treatment with amphotericin B. A National Communicable Disease Center Cooperative Mycoses Study. Am Rev Respir Dis 1969 99 6 895-902
74. Seabury J H., Dascomb H E. Results of the treatment of systemic mycoses. JAMA 1964 188 509-513
75. Abernathy R S. Amphotericin therapy of North American blastomycosis. Antimicrob Agents Chemother (Bethesda) 1966 6 208-211
76. Busey J F. Blastomycosis, III: A comparative study of 2-hydroxystilbamidine and amphotericin B therapy. Am Rev Respir Dis 1972 105 5 812-818
77. Dismukes W E., Stamm A M., Graybill J R. et al. Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. Ann Intern Med 1983 98 1 13-20 (Pubitemid 13217957)
78. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of blastomycosis and histoplasmosis with ketoconazole: results of a prospective randomized clinical trial. Ann Intern Med 1985 103 6 Pt 1 861-872
79. Pitrak D L., Andersen B R. Cerebral blastomycoma after ketoconazole therapy for respiratory tract blastomycosis. Am J Med 1989 86 6 Pt 1 713-714 (Pubitemid 19149357)
80. Dismukes W E., Bradsher R W. Jr, Cloud G C. et al, NIAID Mycoses Study Group. Itraconazole therapy for blastomycosis and histoplasmosis. Am J Med 1992 93 5 489-497
81. Bradsher R W. Blastomycosis. Clin Infect Dis 1992 14 Suppl 1 S82-S90
82. Dodds Ashley E, Lewis R, Lewis J et al. Pharmacology of systemic antifungal agents. Clin Infect Dis 2006 43 Suppl 1 S28-S39 (Pubitemid 44078894)
83. Pappas P G., Bradsher R W., Chapman S W. et al, The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of blastomycosis with fluconazole: a pilot study. Clin Infect Dis 1995 20 2 267-271
84. Pappas P G., Bradsher R W., Kauffman C A. et al, The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of blastomycosis with higher doses of fluconazole. Clin Infect Dis 1997 25 2 200-205 (Pubitemid 27364714)
85. Li R K., Ciblak M A., Nordoff N, Pasarell L, Warnock D W., McGinnis M R. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother 2000 44 6 1734-1736 (Pubitemid 30340829)
86. Sugar A M., Liu X P. Efficacy of voriconazole in treatment of murine pulmonary blastomycosis. Antimicrob Agents Chemother 2001 45 2 601-604 (Pubitemid 32105301)
87. Freifeld A G., Bariola J R., Andes D. The role of second-generation antifungal triazoles for treatment of the endemic mycoses. Curr Infect Dis Rep 2010 12 6 471-478
88. Bakleh M, Aksamit A J., Tleyjeh I M., Marshall W F. Successful treatment of cerebral blastomycosis with voriconazole. Clin Infect Dis 2005 40 9 e69-e71
89. Borgia S M., Fuller J D., Sarabia A, El-Helou P. Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen. Med Mycol 2006 44 7 659-664 (Pubitemid 44650518)
90. Panicker J, Walsh T, Kamani N. Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole. Pediatr Infect Dis J 2006 25 4 377-379
91. Freifeld A, Proia L, Andes D et al. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother 2009 53 4 1648-1651
92. Bariola J R., Perry P, Pappas P G. et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis 2010 50 6 797-804
93. Sabatelli F, Patel R, Mann P A. et al. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 2006 50 6 2009-2015 (Pubitemid 43807519)
94. Sugar A M., Liu X P. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis. Antimicrob Agents Chemother 1996 40 5 1314-1316 (Pubitemid 26141400)
95. Zhanel G G., Karlowsky J A., Harding G A. et al. In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species. Antimicrob Agents Chemother 1997 41 4 863-865 (Pubitemid 27150550)
96. Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998 36 10 2950-2956 (Pubitemid 28429420)
97. Vasquez J E., Mehta J B., Agrawal R, Sarubbi F A. Blastomycosis in northeast Tennessee. Chest 1998 114 2 436-443 (Pubitemid 28387520)
98. Lahm T, Neese S, Thornburg A T., Ober M D., Sarosi G A., Hage C A. Corticosteroids for blastomycosis-induced ARDS: a report of two patients and review of the literature. Chest 2008 133 6 1478-1480 (Pubitemid 351893007)
99. Plamondon M, Lamontagne F, Allard C, Pépin J. Corticosteroids as adjunctive therapy in severe blastomycosis-induced acute respiratory distress syndrome in an immunosuppressed patient. Clin Infect Dis 2010 51 1 e1-e3
100. Wüthrich M, Chang W L., Klein B S. Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis. Infect Immun 1998 66 11 5443-5449 (Pubitemid 29044642)
101. Klein B S. Molecular basis of pathogenicity in Blastomyces dermatitidis: the importance of adhesion. Curr Opin Microbiol 2000 3 4 339-343 (Pubitemid 30640355)
102. Wüthrich M, Krajaejun T, Shearn-Bochsler V et al. Safety, tolerability, and immunogenicity of a recombinant, genetically engineered, live-attenuated vaccine against canine blastomycosis. Clin Vaccine Immunol 2011 18 5 783-789